Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Chronic Obstructive Pulmonary Disease (COPD) in United States

70 results

Sort By:

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

Study ID: NCT06496620
Start Date: 2024-08-14
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

171

Intervention / Treatment

Biological: Solrikitug low dose

Biological: Solrikitug high dose

Placebo

Sponsor

Uniquity One (UNI)

Source: clinicaltrials.gov

Share:
Add to list

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Study ID: NCT03263130
Start Date: 2017-01-01
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap

Sponsor

Gelb, Arthur F., M.D.

Source: clinicaltrials.gov

Share:
Add to list

Accelerated Pulmonary Rehabilitation in the Preoperative Period

Study ID: NCT06432972
Start Date: 2024-01-02
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Pulmonary Rehab

Sponsor

University of Vermont

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD

Study ID: NCT06075095
Start Date: 2024-01-11
End Date: 2025-09-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

255

Intervention / Treatment

BGF MDI HFO 320/14.4/9.6μg

BGF MDI HFA 320/14.4/9.6 μg

Placebo MDI HFA

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

WTC Chest CT Imaging Archive

Study ID: NCT03295279
Start Date: 2012-09-01
End Date: 2026-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2122

Intervention / Treatment
Sponsor

Icahn School of Medicine at Mount Sinai

Source: clinicaltrials.gov

Share:
Add to list

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

Study ID: NCT04179981
Start Date: 2020-12-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment

Positive airway pressure

Conservative care (control arm)

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Study ID: NCT06283966
Start Date: 2024-02-21
End Date: 2028-03-07
Study Type

Interventional

Study Phase

Phase3

No. of Participants

5000

Intervention / Treatment

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

COPD Care Pathway Among Patients With Cancer

Study ID: NCT05984680
Start Date: 2025-02-27
End Date: 2026-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Observational Phase 1

Observational Phase 2, Group I

Observational Phase 2, Group II

Observational Phase 3

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Study ID: NCT06035120
Start Date: 2024-02-22
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

AeriSeal System

Sponsor

Pulmonx Corporation

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Study ID: NCT05878769
Start Date: 2023-06-28
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

2000

Intervention / Treatment

Astegolimab

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list